Microcin MccPDI reduces the prevalence of susceptible Escherichia coli in neonatal calves

L. J. Eberhart, Jennine Ochoa, T. E. Besser, D. R. Call

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aims: Microcin MccPDI-producing Escherichia coli have a fitness advantage in dairy calves. For this project, we determined whether MccPDI is responsible for the in vivo fitness advantage, which is a necessary condition before MccPDI strains can be considered viable candidates for inhibiting pathogenic serovars of E. coli. Methods and Results: Neonatal calves were coinoculated with either MccPDI-producing E. coli or MccPDI-knockout mutants in conjunction with a susceptible strain. After 6 days, the MccPDI-producing E. coli-25 strain clearly dominated the E. coli-186 susceptible strain in the inoculated calves (P = 0·003). MccPDI-producing E. coli composed a higher log percentage of the total population of lactose-fermenting bacteria in the faeces (5·51 log CFU per 8·03 log CFU) compared with the knockout strain (2·6 log CFU per 8·23 log CFU) (P = 0·01), and it was more consistently recovered from the lower gastrointestinal tract at the time of necropsy (P = 0·01). Conclusion: Our findings support the hypothesis that MccPDI is functional in vivo and it is most likely responsible for a fitness advantage in vivo. Significance and Impact of the Study: MccPDI-producing E. coli strongly inhibit pathogenic E. coli strains in vitro. We show herein that MccPDI functions in vivo, and thus, these strains may be candidate probiotics against pathogenic strains of E. coli.

Original languageEnglish (US)
Pages (from-to)340-346
Number of pages7
JournalJournal of Applied Microbiology
Volume117
Issue number2
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Escherichia coli
Lower Gastrointestinal Tract
microcin
Probiotics
Lactose
Feces
Bacteria
Population

Keywords

  • Antimicrobials
  • Bacteriocins
  • Enterohaemorrhagic
  • Food safety
  • Probiotics

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology

Cite this

Microcin MccPDI reduces the prevalence of susceptible Escherichia coli in neonatal calves. / Eberhart, L. J.; Ochoa, Jennine; Besser, T. E.; Call, D. R.

In: Journal of Applied Microbiology, Vol. 117, No. 2, 01.01.2014, p. 340-346.

Research output: Contribution to journalArticle

Eberhart, L. J. ; Ochoa, Jennine ; Besser, T. E. ; Call, D. R. / Microcin MccPDI reduces the prevalence of susceptible Escherichia coli in neonatal calves. In: Journal of Applied Microbiology. 2014 ; Vol. 117, No. 2. pp. 340-346.
@article{cd5fccecfbf5408ebefe0b41381a73de,
title = "Microcin MccPDI reduces the prevalence of susceptible Escherichia coli in neonatal calves",
abstract = "Aims: Microcin MccPDI-producing Escherichia coli have a fitness advantage in dairy calves. For this project, we determined whether MccPDI is responsible for the in vivo fitness advantage, which is a necessary condition before MccPDI strains can be considered viable candidates for inhibiting pathogenic serovars of E. coli. Methods and Results: Neonatal calves were coinoculated with either MccPDI-producing E. coli or MccPDI-knockout mutants in conjunction with a susceptible strain. After 6 days, the MccPDI-producing E. coli-25 strain clearly dominated the E. coli-186 susceptible strain in the inoculated calves (P = 0·003). MccPDI-producing E. coli composed a higher log percentage of the total population of lactose-fermenting bacteria in the faeces (5·51 log CFU per 8·03 log CFU) compared with the knockout strain (2·6 log CFU per 8·23 log CFU) (P = 0·01), and it was more consistently recovered from the lower gastrointestinal tract at the time of necropsy (P = 0·01). Conclusion: Our findings support the hypothesis that MccPDI is functional in vivo and it is most likely responsible for a fitness advantage in vivo. Significance and Impact of the Study: MccPDI-producing E. coli strongly inhibit pathogenic E. coli strains in vitro. We show herein that MccPDI functions in vivo, and thus, these strains may be candidate probiotics against pathogenic strains of E. coli.",
keywords = "Antimicrobials, Bacteriocins, Enterohaemorrhagic, Food safety, Probiotics",
author = "Eberhart, {L. J.} and Jennine Ochoa and Besser, {T. E.} and Call, {D. R.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/jam.12535",
language = "English (US)",
volume = "117",
pages = "340--346",
journal = "Journal of Applied Microbiology",
issn = "1364-5072",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Microcin MccPDI reduces the prevalence of susceptible Escherichia coli in neonatal calves

AU - Eberhart, L. J.

AU - Ochoa, Jennine

AU - Besser, T. E.

AU - Call, D. R.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Aims: Microcin MccPDI-producing Escherichia coli have a fitness advantage in dairy calves. For this project, we determined whether MccPDI is responsible for the in vivo fitness advantage, which is a necessary condition before MccPDI strains can be considered viable candidates for inhibiting pathogenic serovars of E. coli. Methods and Results: Neonatal calves were coinoculated with either MccPDI-producing E. coli or MccPDI-knockout mutants in conjunction with a susceptible strain. After 6 days, the MccPDI-producing E. coli-25 strain clearly dominated the E. coli-186 susceptible strain in the inoculated calves (P = 0·003). MccPDI-producing E. coli composed a higher log percentage of the total population of lactose-fermenting bacteria in the faeces (5·51 log CFU per 8·03 log CFU) compared with the knockout strain (2·6 log CFU per 8·23 log CFU) (P = 0·01), and it was more consistently recovered from the lower gastrointestinal tract at the time of necropsy (P = 0·01). Conclusion: Our findings support the hypothesis that MccPDI is functional in vivo and it is most likely responsible for a fitness advantage in vivo. Significance and Impact of the Study: MccPDI-producing E. coli strongly inhibit pathogenic E. coli strains in vitro. We show herein that MccPDI functions in vivo, and thus, these strains may be candidate probiotics against pathogenic strains of E. coli.

AB - Aims: Microcin MccPDI-producing Escherichia coli have a fitness advantage in dairy calves. For this project, we determined whether MccPDI is responsible for the in vivo fitness advantage, which is a necessary condition before MccPDI strains can be considered viable candidates for inhibiting pathogenic serovars of E. coli. Methods and Results: Neonatal calves were coinoculated with either MccPDI-producing E. coli or MccPDI-knockout mutants in conjunction with a susceptible strain. After 6 days, the MccPDI-producing E. coli-25 strain clearly dominated the E. coli-186 susceptible strain in the inoculated calves (P = 0·003). MccPDI-producing E. coli composed a higher log percentage of the total population of lactose-fermenting bacteria in the faeces (5·51 log CFU per 8·03 log CFU) compared with the knockout strain (2·6 log CFU per 8·23 log CFU) (P = 0·01), and it was more consistently recovered from the lower gastrointestinal tract at the time of necropsy (P = 0·01). Conclusion: Our findings support the hypothesis that MccPDI is functional in vivo and it is most likely responsible for a fitness advantage in vivo. Significance and Impact of the Study: MccPDI-producing E. coli strongly inhibit pathogenic E. coli strains in vitro. We show herein that MccPDI functions in vivo, and thus, these strains may be candidate probiotics against pathogenic strains of E. coli.

KW - Antimicrobials

KW - Bacteriocins

KW - Enterohaemorrhagic

KW - Food safety

KW - Probiotics

UR - http://www.scopus.com/inward/record.url?scp=84904551820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904551820&partnerID=8YFLogxK

U2 - 10.1111/jam.12535

DO - 10.1111/jam.12535

M3 - Article

C2 - 24797067

AN - SCOPUS:84904551820

VL - 117

SP - 340

EP - 346

JO - Journal of Applied Microbiology

JF - Journal of Applied Microbiology

SN - 1364-5072

IS - 2

ER -